Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_C8,15 | Lung | Primary cancer | 222 | Other | 64.4% | 0.89 | 0.30 |
| NSCLC_38242124__IMC__178_C8,16 | Lung | Primary cancer | 7,014 | Immune | 91.8% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__178_C8,17 | Lung | Primary cancer | 2,871 | Other | 93.7% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__178_C8,2 | Lung | Primary cancer | 4,815 | Tumor/Malignant | 85.4% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__178_C8,3 | Lung | Primary cancer | 745 | Tumor/Malignant | 35.6% | 0.87 | 0.24 |
| NSCLC_38242124__IMC__178_C8,4 | Lung | Primary cancer | 3,888 | Immune | 47.5% | 0.90 | 0.28 |
| NSCLC_38242124__IMC__178_C8,5 | Lung | Primary cancer | 2,405 | Tumor/Malignant | 33.1% | 0.55 | 0.81 |
| NSCLC_38242124__IMC__178_C8,6 | Lung | Primary cancer | 4,252 | Tumor/Malignant | 70.9% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__178_C8,8 | Lung | Primary cancer | 3,902 | Tumor/Malignant | 48.7% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__178_C8,9 | Lung | Primary cancer | 3,102 | Tumor/Malignant | 62.5% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__86_A1,1 | Lung | Primary cancer | 2,414 | Stromal | 33.0% | 0.78 | 0.55 |
| NSCLC_38242124__IMC__86_A1,10 | Lung | Primary cancer | 1,094 | Stromal | 36.4% | 0.70 | 0.67 |
| NSCLC_38242124__IMC__86_A1,11 | Lung | Primary cancer | 2,660 | Tumor/Malignant | 46.2% | 0.92 | 0.19 |
| NSCLC_38242124__IMC__86_A1,13 | Lung | Primary cancer | 4,008 | Tumor/Malignant | 50.5% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__86_A1,14 | Lung | Primary cancer | 3,589 | Stromal | 35.0% | 0.66 | 0.70 |
| NSCLC_38242124__IMC__86_A1,2 | Lung | Primary cancer | 3,803 | Tumor/Malignant | 26.4% | 0.86 | 0.50 |
| NSCLC_38242124__IMC__86_A1,5 | Lung | Primary cancer | 2,479 | Stromal | 31.7% | 0.54 | 0.81 |
| NSCLC_38242124__IMC__86_A1,6 | Lung | Primary cancer | 4,205 | Tumor/Malignant | 49.3% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__86_A1,7 | Lung | Primary cancer | 2,829 | Tumor/Malignant | 43.0% | 0.91 | 0.33 |
| NSCLC_38242124__IMC__86_A1,8 | Lung | Primary cancer | 844 | Stromal | 47.3% | 0.89 | 0.22 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_C8,15 | Lung | Primary cancer | 222 | Other | 64.4% | 0.89 | 0.30 |
| NSCLC_38242124__IMC__178_C8,16 | Lung | Primary cancer | 7,014 | Lymphoid | 82.6% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__178_C8,17 | Lung | Primary cancer | 2,871 | Other | 93.7% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__178_C8,2 | Lung | Primary cancer | 4,815 | Tumor/Malignant | 81.4% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_C8,3 | Lung | Primary cancer | 745 | Tumor/Malignant | 41.6% | 0.86 | 0.30 |
| NSCLC_38242124__IMC__178_C8,4 | Lung | Primary cancer | 3,888 | Lymphoid | 37.6% | 0.91 | 0.28 |
| NSCLC_38242124__IMC__178_C8,5 | Lung | Primary cancer | 2,405 | Tumor/Malignant | 29.3% | 0.86 | 0.37 |
| NSCLC_38242124__IMC__178_C8,6 | Lung | Primary cancer | 4,252 | Tumor/Malignant | 70.6% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__178_C8,8 | Lung | Primary cancer | 3,902 | Tumor/Malignant | 42.6% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__178_C8,9 | Lung | Primary cancer | 3,102 | Tumor/Malignant | 46.2% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_A1,1 | Lung | Primary cancer | 2,414 | Stromal | 22.0% | 0.53 | 0.87 |
| NSCLC_38242124__IMC__86_A1,10 | Lung | Primary cancer | 1,094 | Stromal | 27.6% | 0.49 | 0.95 |
| NSCLC_38242124__IMC__86_A1,11 | Lung | Primary cancer | 2,660 | Tumor/Malignant | 38.2% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__86_A1,13 | Lung | Primary cancer | 4,008 | Tumor/Malignant | 30.3% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__86_A1,14 | Lung | Primary cancer | 3,589 | Stromal | 23.8% | 0.75 | 0.64 |
| NSCLC_38242124__IMC__86_A1,2 | Lung | Primary cancer | 3,803 | Tumor/Malignant | 30.0% | 0.54 | 0.91 |
| NSCLC_38242124__IMC__86_A1,5 | Lung | Primary cancer | 2,479 | Stromal | 26.3% | 0.87 | 0.35 |
| NSCLC_38242124__IMC__86_A1,6 | Lung | Primary cancer | 4,205 | Tumor/Malignant | 57.2% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__86_A1,7 | Lung | Primary cancer | 2,829 | Tumor/Malignant | 35.5% | 0.94 | 0.26 |
| NSCLC_38242124__IMC__86_A1,8 | Lung | Primary cancer | 844 | Stromal | 45.7% | 0.90 | 0.20 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_C8,15 | Lung | Primary cancer | 222 | Other | 64.4% | 0.89 | 0.30 |
| NSCLC_38242124__IMC__178_C8,16 | Lung | Primary cancer | 7,014 | B cell | 68.4% | 0.96 | 0.11 |
| NSCLC_38242124__IMC__178_C8,17 | Lung | Primary cancer | 2,871 | Other | 93.5% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__178_C8,2 | Lung | Primary cancer | 4,815 | Tumor/Malignant cell | 85.6% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__178_C8,3 | Lung | Primary cancer | 745 | Tumor/Malignant cell | 47.9% | 0.82 | 0.38 |
| NSCLC_38242124__IMC__178_C8,4 | Lung | Primary cancer | 3,888 | T cell | 27.6% | 0.83 | 0.49 |
| NSCLC_38242124__IMC__178_C8,5 | Lung | Primary cancer | 2,405 | Tumor/Malignant cell | 39.4% | 0.82 | 0.49 |
| NSCLC_38242124__IMC__178_C8,6 | Lung | Primary cancer | 4,252 | Tumor/Malignant cell | 70.7% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__178_C8,8 | Lung | Primary cancer | 3,902 | Tumor/Malignant cell | 49.6% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__178_C8,9 | Lung | Primary cancer | 3,102 | Tumor/Malignant cell | 62.4% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__86_A1,1 | Lung | Primary cancer | 2,414 | Fibroblast | 31.0% | 0.78 | 0.56 |
| NSCLC_38242124__IMC__86_A1,10 | Lung | Primary cancer | 1,094 | Fibroblast | 37.2% | 0.67 | 0.76 |
| NSCLC_38242124__IMC__86_A1,11 | Lung | Primary cancer | 2,660 | Tumor/Malignant cell | 46.6% | 0.91 | 0.20 |
| NSCLC_38242124__IMC__86_A1,13 | Lung | Primary cancer | 4,008 | Tumor/Malignant cell | 51.3% | 0.92 | 0.25 |
| NSCLC_38242124__IMC__86_A1,14 | Lung | Primary cancer | 3,589 | Fibroblast | 34.8% | 0.50 | 0.95 |
| NSCLC_38242124__IMC__86_A1,2 | Lung | Primary cancer | 3,803 | Tumor/Malignant cell | 32.7% | 0.80 | 0.62 |
| NSCLC_38242124__IMC__86_A1,5 | Lung | Primary cancer | 2,479 | Fibroblast | 35.2% | 0.82 | 0.47 |
| NSCLC_38242124__IMC__86_A1,6 | Lung | Primary cancer | 4,205 | Tumor/Malignant cell | 73.0% | 0.94 | 0.17 |
| NSCLC_38242124__IMC__86_A1,7 | Lung | Primary cancer | 2,829 | Tumor/Malignant cell | 42.6% | 0.91 | 0.33 |
| NSCLC_38242124__IMC__86_A1,8 | Lung | Primary cancer | 844 | Fibroblast | 41.8% | 0.80 | 0.34 |